vTv Therapeutics Inc. (NASDAQ:VTVT) filed a Form 8-K with the Securities and Exchange Commission on February 02, 2026, disclosing a material event.
vTv Therapeutics Inc.'s stock currently trades at $38.31 with a market capitalization of $90.3M. The Healthcare company's stock moved following the disclosure.